4//SEC Filing
Cotreau Violetta 4
Accession 0001562180-22-002164
CIK 0001517022other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 9:12 PM ET
Size
12.9 KB
Accession
0001562180-22-002164
Insider Transaction Report
Form 4
Cotreau Violetta
SVP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2022-02-28$2.15/sh−3,946$8,503→ 29,121 total - Award
Common Stock
2022-02-28+40,833→ 69,954 total - Award
Employee Stock Option (Right to buy)
2022-02-28+70,000→ 70,000 totalExercise: $2.16Exp: 2032-02-28→ Common Stock (70,000 underlying)
Footnotes (3)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.
- [F2]The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One-third of the restricted stock units will become vested on the first anniversary of the grant date; and the remaining 2/3 of the Shares will vest in substantially equal quarterly installments thereafter, at the beginning of each of the following eight calendar quarters, subject to the reporting person's continued service with the Issuer on each vesting date.
- [F3]The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001841934
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 9:12 PM ET
- Size
- 12.9 KB